We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$2.39B
AUM Growth
+$171M
(+7.7%)
Cap. Flow
+$33.3M
Cap. Flow
% of AUM
1.4%
Top 10 Holdings %
Top 10 Hldgs %
35.58%
Holding
318
New
36
Increased
76
Reduced
22
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Equal Weighted ETF
EUSA
|
+$13.3M |
| 2 |
Caterpillar
CAT
|
+$11.8M |
| 3 |
Vertiv
VRT
|
+$9.23M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$1.11M |
| 5 |
iShares MSCI Japan ETF
EWJ
|
+$1.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$13.5M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$6.68M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$4.93M |
| 4 |
Deckers Outdoor
DECK
|
+$1.35M |
| 5 |
Henry Schein
HSIC
|
+$845K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.15% |
| 2 | Industrials | 14.13% |
| 3 | Financials | 12.77% |
| 4 | Healthcare | 9.64% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Janus International
JBI
$667M
| $207K | 0.01% |
+20,442
| New | +$238K |
|
302
OmniAb
OABI
$650M
| $159K | 0.01% |
37,507
+12,462
| +50% | +$53.9K |
|
303
America Movil
AMX
$69.4B
| – | – |
-15,019
| Closed | -$255K |
|
304
Atkore
ATKR
$3.16B
| – | – |
-2,177
| Closed | -$294K |
|
305
Bank of Montreal
BMO
$120B
| – | – |
-2,743
| Closed | -$230K |
|
|
306
Deckers Outdoor
DECK
$12B
| – | – |
-8,364
| Closed | -$1.35M |
|
307
Elastic
ESTC
$10.4B
| – | – |
-1,955
| Closed | -$223K |
|
308
Helen of Troy
HELE
$667M
| – | – |
-2,961
| Closed | -$275K |
|
|
309
Henry Schein
HSIC
$9.98B
| – | – |
-13,182
| Closed | -$845K |
|
310
Huntsman Corp
HUN
$1.66B
| – | – |
-11,271
| Closed | -$257K |
|
|
ONT
311
Onterris Inc
ONT
$598M
| – | – |
-5,663
| Closed | -$252K |
|
312
MACOM Technology Solutions
MTSI
$20.3B
| – | – |
-6,177
| Closed | -$689K |
|
313
MaxLinear
MXL
$5.6B
| – | – |
-15,016
| Closed | -$302K |
|
314
Pacira BioSciences
PCRX
$1.03B
| – | – |
-12,512
| Closed | -$358K |
|
|
315
Vanguard FTSE All-World ex-US ETF
VEU
$70.4B
| – | – |
-114,000
| Closed | -$6.68M |
|
|
316
Vanguard Dividend Appreciation ETF
VIG
$113B
| – | – |
-26,988
| Closed | -$4.93M |
|
317
Ziff Davis
ZD
$1.91B
| – | – |
-4,733
| Closed | -$261K |
|
|
SWN
318
DELISTED
Southwestern Energy Company
SWN
| – | – |
-16,750
| Closed | -$113K |
|
Similar funds
DMIC
SAM
PCM
CI
BAM
SFS
WWM
WG
Henshaw Capital's Q3 2024 Portfolio in Review
As of Q3 2024, Henshaw Capital held 318 positions worth $2.39B, up 7.7% from $2.22B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Henshaw Capital's Q3 2024 filing shows 36 new, 76 increased, 22 reduced and 16 closed positions. Its largest new stake was Caterpillar: 34,060 shares worth $13.3M. The largest sale was Pfizer, an estimated $13.5M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Industrials and Financials.
- Henshaw Capital's largest Q3 2024 buy was Caterpillar: 34,060 shares worth $13.3M.
- Henshaw Capital added most to iShares MSCI USA Equal Weighted ETF in Q3 2024, an estimated $13.3M increase.
- Henshaw Capital's biggest Q3 2024 reduction was Pfizer, cutting an estimated $13.5M.
- Henshaw Capital fully exited Vanguard FTSE All-World ex-US ETF in Q3 2024, selling an estimated $6.68M.
- Henshaw Capital's ten largest holdings make up 36% of its $2.39B portfolio in Q3 2024.
- Henshaw Capital opened 36 new positions and closed 16 in Q3 2024.
- Henshaw Capital's portfolio value rose 7.7% quarter-over-quarter to $2.39B.
Based on Henshaw Capital's 13F filing for Q3 2024, filed 28 May 2026.